Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

SHE/300595 stock hub

SHE/300595 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/300595is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

12.7B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/300595

In the news

Latest news · SHE/300595

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E18.8

P25 17.1P50 24.2P75 37.8

Trailing P/E27.2

P25 23.5P50 41.3P75 83.2

ROE9.8

P25 -0.9P50 4.1P75 8.8

ROIC17.4

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/300595 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

236

Groups with data

Currency

CNY

Showing 236 of 236 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	3,752
Employees Change	172%
Employees Change Percent	4.8
Enterprise value	CNY 11B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Isin	CNE100002MR0
Last refreshed	2026-05-10
Market cap	CNY 12.7B
Price	CNY 14.18
Price currency	CNY
Rev Per Employee	491,040.26x
Sector	Healthcare
Sic	3851
Symbol	she/300595
Website	https://www.orthok.cn

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.67%
EV Earnings	23.65x
EV/EBIT	18.29x
EV/EBITDA	14.4x
EV/FCF	18.98x
EV/Sales	5.97x
FCF yield	4.57%
Forward P/E	18.8x
P/B ratio	2.3x
P/E ratio	27.18x
P/S ratio	6.89x
PE Ratio10 Y	58.96x
PE Ratio3 Y	28.99x
PE Ratio5 Y	50.62x
PEG ratio	2.76x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	32.67%
EBITDA Margin	35.96%
FCF margin	31.48%
Gross margin	71.08%
Gross Profit	CNY 1.3B
Gross Profit Growth	-2.13%
Gross Profit Growth Q	-9.31%
Gross Profit Growth3 Y	2.97%
Gross Profit Growth5 Y	9.64%
Net Income	CNY 465.4M
Net Income Growth	-13.74%
Net Income Growth Q	-8.79%
Net Income Growth Years	0%
Net Income Growth3 Y	-10.49%
Net Income Growth5 Y	-2.69%
Pretax Margin	34.23%
Profit Margin	25.26%
Profit Per Employee	CNY 124,050
Profitable Years	14
ROA	5.93
Roa5y	9.61
ROCE	10.54
ROE	9.83
Roe5y	16.85
ROIC	17.44
Roic5y	39.26

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-4.62%
Cagr3y	-22.54%
Cagr5y	-28.65%
Div CAGR3	24.24%
Div CAGR5	31.42%
EPS Growth	-13.59
EPS Growth Q	-8.5
EPS Growth Years	0
EPS Growth3 Y	-10.84
EPS Growth5 Y	-3.63
FCF Growth	14.73%
FCF Growth Q	-18.38%
FCF Growth3 Y	2.07%
FCF Growth5 Y	6.28%
OCF Growth	-0.77%
OCF Growth Q	-24.65%
OCF Growth10 Y	29%
OCF Growth3 Y	-0.19%
OCF Growth5 Y	5.18%
Revenue Growth	0.83x
Revenue Growth Q	-3.92x
Revenue Growth Years	13x
Revenue Growth3 Y	5.8x
Revenue Growth5 Y	11.82x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.29
Assets	CNY 6.4B
Cash	CNY 2.4B
Current Assets	CNY 4.1B
Current Liabilities	CNY 694M
Debt	CNY 220.2M
Debt EBITDA	CNY 0.29
Debt Equity	CNY 0.04
Debt FCF	CNY 0.38
Equity	CNY 5.5B
Interest Coverage	48.27
Liabilities	CNY 872.8M
Long Term Assets	CNY 2.4B
Long Term Liabilities	CNY 178.8M
Net Cash	CNY 2.2B
Net Cash By Market Cap	CNY 16.98
Net Cash Growth	18.89%
Net Debt EBITDA	CNY -3.25
Net Debt Equity	CNY -0.39
Net Debt FCF	CNY -3.72
Tangible Book Value	CNY 4.2B
Tangible Book Value Per Share	CNY 4.66
WACC	7.95

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.84
Inventory Turnover	3.16
Net Working Capital	CNY 1.1B
Quick ratio	3.96
Working Capital	CNY 3.4B
Working Capital Turnover	CNY 0.55

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.17%
Dividend Growth	0%
Dividend Growth Years	2%
Dividend per share	CNY 0.15
Dividend Years	9
Dividend Yield	1.07%
Ex Div Date	2025-11-05
Last Dividend	CNY 0.06
Payout Frequency	Annual
Payout Ratio	54.73%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-4.62%
200-day SMA	16.19
3Y total return	-53.54%
50-day SMA	14.68
50-day SMA vs 200-day SMA	50under200
5Y total return	-81.5%
All Time High	109.7
All Time High Change	-87.07%
All Time High Date	2021-06-23
All Time Low	2.33
All Time Low Change	507.8%
All Time Low Date	2017-01-17
ATR	0.37
Beta	0.68
Beta1y	0.46
Beta2y	0.87
Ch YTD	-3.47
High	14.29
High52	19.98
High52 Date	2025-08-19
High52ch	-29.03%
Low	14.11
Low52	13.76
Low52 Date	2026-04-07
Low52ch	3.05%
Ma50ch	-3.43%
Price vs 200-day SMA	-12.42%
RSI	45.34
RSI Monthly	38.54
RSI Weekly	39.56
Sharpe ratio	-0.07x
Sortino ratio	0.12
Total Return	1.24%
Tr YTD	-3.47
Tr1m	2.61%
Tr1w	-1.12%
Tr3m	-10.08%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 601.9M
Operating Income Growth	-10.21
Operating Income Growth Q	-16.77
Operating Income Growth3 Y	-6.2
Operating Income Growth5 Y	2.99
Operating margin	32.67

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	467,128,934%
Net Borrowing	-322,102,295
Shares Insiders	33.51%
Shares Institutions	7.02%
Shares Out	895,289,123
Shares Qo Q	0.03%
Shares Yo Y	-0.17%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 580.1M
Average Volume	9,682,867.75x
Bv Per Share	5.65
CAPEX	CNY -101.2M
Ch1m	2.61
Ch1w	-1.12
Ch1y	-6.34
Ch3m	-10.08
Ch3y	-55.13
Ch5y	-82.23
Ch6m	-13.64
Change	0%
Change From Open	0.5
Close	14.18
Days Gap	-0.49
Depreciation Amortization	60,662,776
Dollar Volume	107,701,453.3
Earnings Date	2026-08-20
EBIT	CNY 601.9M
EBITDA	CNY 662.5M
EPS	CNY 0.52
F Score	5
FCF	CNY 580.1M
FCF EV Yield	5.27x
FCF Per Share	CNY 0.65
Financing CF	-597,584,634
Fiscal Year End	December
Founded	2,000
Goodwill	866,904,395
Graham Number	8.14488
Graham Upside	-42.56
Income Tax	CNY 96.2M
Investing CF	237,524,681
Is Primary Listing	1
Last Earnings Date	2026-03-28
Last Report Date	2026-03-31
Last Split Date	2021-05-21
Last Split Type	Forward
Lynch Fair Value	CNY 2.61
Lynch Upside	-81.61
Ma150	15.62
Ma150ch	-9.19%
Ma20	14.23
Ma20ch	-0.34%
Net CF	321,196,519
Next Earnings Date	2026-08-20
Open	14.11
P FCF Ratio	21.89
P OCF Ratio	18.63
Payment Date	2025-11-05
Position In Range	38.89
Ppne	637,752,983
Price Date	2026-05-08
Price EBITDA	CNY 19.16
Ptbv Ratio	3.04
Relative Volume	0.8x
Revenue	1,842,383,038x
Tax By Revenue	5.22x
Tax Rate	15.25%
Tr6m	-13.64%
Volume	7,595,307
Z Score	11.82

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/300595 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.1%

$0.15 annual per share

Payout ratio

+54.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+31.4%

2 consecutive years of growth

Total shareholder yield

+1.2%

Next ex-dividend date: 2025-11-05

Performance

SHE/300595 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/300595?

Insider, institutional, and short-interest positioning.

Institutional ownership

+7.0%

Share of float held by funds and institutions

Insider ownership

+33.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.2%

Negative means the company is buying back shares.

Technical

SHE/300595 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.3

Neutral momentum band

Price vs 200-day MA

-12.4%

50/200-day relationship not available

Beta (5Y)

0.68

Less volatile than the market

Sharpe ratio

-0.07

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/300595

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/300595 stock rating?

she/300595 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/300595 analysis?

The full report lives at /stocks/she/300595/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/300595?

The latest report frames she/300595 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/300595 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.